We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+12.66%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.6B
AUM Growth
+$492M
Cap. Flow
+$29.6M
Cap. Flow %
0.64%
Top 10 Hldgs %
30.7%
Holding
1,209
New
99
Increased
196
Reduced
300
Closed
114

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$49.2M
2
EXPD icon
Expeditors International
EXPD
+$25M
3
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$17.2M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$7.71M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.24M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$32.4M
2
LHX icon
L3Harris
LHX
+$11.9M
3
V icon
Visa
V
+$7.78M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.6M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 17.94%
3 Financials 12.59%
4 Consumer Discretionary 10.3%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HR
1001
DELISTED
Healthcare Realty Trust Incorporated
HR
$3K ﹤0.01%
100
– –
AEVA
1002
Aeva Technologies
AEVA
$1.02B
$2K ﹤0.01%
43
– –
ANSS
1003
DELISTED
Ansys
ANSS
$2K ﹤0.01%
4
– –
BBIO icon
1004
BridgeBio Pharma
BBIO
$16.5B
$2K ﹤0.01%
+131
New +$5.54K
CFG icon
1005
Citizens Financial Group
CFG
$30.4B
$2K ﹤0.01%
40
– –
CLOU icon
1006
Global X Cloud Computing ETF
CLOU
$224M
$2K ﹤0.01%
83
– –
FITB
1007
Fifth Third Bancorp
FITB
$52B
$2K ﹤0.01%
50
– –
B
1008
Barrick Mining
B
$62.2B
$2K ﹤0.01%
100
– –
HES
1009
DELISTED
Hess
HES
$2K ﹤0.01%
25
– –
HOOD icon
1010
Robinhood
HOOD
$85.2B
$2K ﹤0.01%
100
-500
-83% -$15.4K
IQ icon
1011
iQIYI
IQ
$1.18B
$2K ﹤0.01%
513
– –
LITE icon
1012
Lumentum
LITE
$59.4B
$2K ﹤0.01%
+20
New +$1.82K
MGM icon
1013
MGM Resorts International
MGM
$11.7B
$2K ﹤0.01%
45
– –
NTAP icon
1014
NetApp
NTAP
$32.9B
$2K ﹤0.01%
20
– –
PARA
1015
DELISTED
Paramount Global Class B
PARA
$2K ﹤0.01%
56
-310
-85% -$10.7K
PCAR icon
1016
PACCAR
PCAR
$69.6B
$2K ﹤0.01%
38
-49
-56% -$2.83K
PHAT icon
1017
Phathom Pharmaceuticals
PHAT
$912M
$2K ﹤0.01%
+111
New +$2.61K
RF icon
1018
Regions Financial
RF
$26.3B
$2K ﹤0.01%
100
-309
-76% -$7.07K
SLV icon
1019
iShares Silver Trust
SLV
$28.1B
$2K ﹤0.01%
116
+36
+45% +$778
SOFI icon
1020
SoFi Technologies
SOFI
$21.1B
$2K ﹤0.01%
100
– –
STOK icon
1021
Stoke Therapeutics
STOK
$1.82B
$2K ﹤0.01%
+99
New +$2.36K
TDG icon
1022
TransDigm Group
TDG
$69.2B
$2K ﹤0.01%
3
– –
ULTA icon
1023
Ulta Beauty
ULTA
$20.4B
$2K ﹤0.01%
4
– –
VIAV icon
1024
Viavi Solutions
VIAV
$9.75B
$2K ﹤0.01%
100
-46
-32% -$729
WDC icon
1025
Western Digital
WDC
$179B
$2K ﹤0.01%
33
– –
39 40
41
42 43

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q4 2021 Portfolio in Review

As of Q4 2021, HM Payson & Co held 1,209 positions worth $4.6B, up 12% from $4.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q4 2021 filing shows 99 new, 196 increased, 300 reduced and 114 closed positions. Its largest new stake was Peoples Bancorp: 23,400 shares worth $744K. The largest sale was Amgen, an estimated $32.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q4 2021 buy was Peoples Bancorp: 23,400 shares worth $744K.
  • HM Payson & Co added most to CVS Health in Q4 2021, an estimated $49.2M increase.
  • HM Payson & Co's biggest Q4 2021 reduction was Amgen, cutting an estimated $32.4M.
  • HM Payson & Co fully exited Invesco BulletShares 2021 Corporate Bond ETF in Q4 2021, selling an estimated $5.01M.
  • HM Payson & Co's ten largest holdings make up 31% of its $4.6B portfolio in Q4 2021.
  • HM Payson & Co opened 99 new positions and closed 114 in Q4 2021.
  • HM Payson & Co's portfolio value rose 12% quarter-over-quarter to $4.6B.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.